HMedical ResearchEIN: 273232063· Ruling Year: 2014

Cancer Genomics Consortium

Fletcher, North Carolina

BHealth Score
62B

Financial Health Score

8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.

Above Average

💰
$441K
Total Revenue
📊
$447K
Total Expenses
🏦
$507K
Net Assets
📋
$74K
Total Liabilities

Financial Trends

5-Year Trend Analysis

Financial Health Indicators

Revenue Growth
-6.5%
Year-over-year change (2022 → 2023)
Net Margin
-1.2%
Revenue minus expenses as % of revenue
Working Capital Ratio
1.13
Net assets divided by total expenses
Liabilities-to-Assets
12.7%
Total liabilities as % of total assets

Filing History

11 filings on record
YearRevenueExpensesAssets
2023$441,0407%$446,54717%$580,1209%
2022$471,89763%$380,318111%$534,56214%
2021$289,07086%$180,64224%$470,21030%
2020$155,53452%$145,20553%$361,83520%
2019$327,43513%$308,91119%$301,7077%
2018$288,81139%$258,88433%$283,18312%
2017$207,16141%$194,27726%$253,2565%
2016$147,17413%$154,64575%$240,3723%
2015$170,08833%$88,22729%$247,84349%
2014$127,71535%$124,52517%$165,9822%
2013$197,282$150,891$162,792

Frequently Asked Questions

What does Cancer Genomics Consortium do?

Cancer Genomics Consortium is a medical research nonprofit organization based in North Carolina. It is classified under NTEE code H12 and is registered as a 501(c) tax-exempt organization with the IRS.

Is Cancer Genomics Consortium financially healthy?

Financial health scoring requires Form 990 filing data. Check back as we process more filings for Cancer Genomics Consortium.

How much revenue does Cancer Genomics Consortium generate?

Cancer Genomics Consortium reports $437K in annual revenue and holds $556K in total assets, based on IRS filings.

Similar Organizations

Explore more organizations in the Medical Research category, or browse all nonprofits in North Carolina.